Melanoma (Issue 1) | Special Reports

Two BRAF Fusions Discovered in Some Pan-Negative Melanomas

December 21, 2013

Clinical Articles

The discovery of two unique molecular targets known to speed skin-cancer growth has researchers excited that they might soon understand and develop genetic therapies geared toward some of medicine’s most untreatable melanomas.

Understanding the Biologic Pathways in Basal Cell Carcinoma

December 21, 2013

Clinical Articles

Most cases of BCC are curable with such approaches as surgery and radiation. In some cases, however, BCC can progress to a point of local invasion for which surgery and radiation therapy are not indicated.

Advances in Metastatic Melanoma

December 21, 2013

Clinical Articles

Although the diagnosis of late-stage melanoma is still associated with a poor prognosis, an encouraging number of new therapies have been developed during the last 3 years.

The Outlook for BRAF Inhibitors in Melanoma

December 18, 2013

Clinical Articles

Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the outlook for BRAF inhibitors in melanoma.

The Treatment of Melanoma With Emerging Targeted Therapies

December 17, 2013

Clinical Articles

Georgina Long, BSc, PhD, MBBS, FRACP, medical oncologist, translational researcher, Melanoma Institute Australia, The University of Sydney, discusses the treatment of melanoma with emerging targeted therapies.

The Challenges of Treating Metastatic Melanoma With BRAF Inhibitor Monotherapy

December 17, 2013

Clinical Articles

Adil Daud, MD, clinical professor, medicine, dermatology, University of California, San Francisco, discusses the challenges of treating patients with metastatic melanoma with BRAF inhibitor monotherapy.